Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Nov 13, 2018

SELL
$2.85 - $3.19 $583,514 - $653,126
-204,742 Closed
0 $0
Q2 2018

Aug 09, 2018

SELL
$3.04 - $3.93 $529,896 - $685,030
-174,308 Reduced 45.99%
204,742 $624,000
Q1 2018

May 03, 2018

SELL
$2.96 - $4.0 $714,464 - $965,492
-241,373 Reduced 38.9%
379,050 $1.17 Million
Q4 2017

Feb 14, 2018

SELL
$3.38 - $4.74 $271,096 - $380,176
-80,206 Reduced 11.45%
620,423 $2.02 Million
Q3 2017

Nov 15, 2017

SELL
$3.3 - $4.42 $42,969 - $57,552
-13,021 Reduced 1.82%
700,629 $3.1 Million
Q2 2017

Aug 15, 2017

BUY
N/A
713,650
713,650 $2.99 Million

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $46.4M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Argent Capital Management LLC Portfolio

Follow Argent Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.